DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Appeal No. 7060 of 2026 filed by HAWA SINGH

SEBI 1 hr ago·17 Sept 2026, 12:38 pm

Company SEBI

Hawa Singh has filed an appeal in 2026, which is a formal request to a higher court to review a previous legal decision. This legal action is currently pending and has no immediate impact on the day-to-day operations or financial results of the company. The appeal could potentially alter the legal outcome in the future, but it is too early to determine the final result or its consequences.

For investors, this development is currently neutral. The stock's value is unlikely to be affected in the short term, as the appeal is a standard legal process. Investors should focus on the company's core business performance and wait for further updates from the court. It is important to avoid making investment decisions based solely on this news.